BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 7461541)

  • 1. [Drug treatment of benign breast diseases].
    Schulz KD
    Fortschr Med; 1980 Sep; 98(36):1359-64. PubMed ID: 7461541
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Antiprolactin therapy in the treatment of benign lesions of the breast. Comparison of bromocryptine and methergoline].
    Mussa A; Sandrucci S; Dogliotti L
    Minerva Med; 1979 Nov; 70(51):3493-8. PubMed ID: 522987
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Benign breast disease.
    Mauvais-Jarvis P; Kuttenn F
    Curr Ther Endocrinol Metab; 1994; 5():364-70. PubMed ID: 7704754
    [No Abstract]   [Full Text] [Related]  

  • 4. [Mastodynia and fibrocystic disease of the breast. Perspectives and methods of medical treatment].
    van Bogaert LJ
    J Gynecol Obstet Biol Reprod (Paris); 1986; 15(6):805-11. PubMed ID: 3794218
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Nonpuerperal mastitis--a disease with increasing clinical relevance?].
    Pahnke VG; Kitschke HJ; Bernauer M; Koll R
    Geburtshilfe Frauenheilkd; 1985 Jan; 45(1):29-35. PubMed ID: 3872244
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Management of breast pain.
    Faiz O; Fentiman IS
    Int J Clin Pract; 2000 May; 54(4):228-32. PubMed ID: 10912311
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Premenstrual syndrome and its treatment. The role of progestagens].
    Bursaux CD; Paris J; Pintiaux C; Delecour M; Belaisch J; Rozenbaum H
    Rev Fr Gynecol Obstet; 1985 Oct; 80(10):753-62. PubMed ID: 3909348
    [No Abstract]   [Full Text] [Related]  

  • 8. Treatment of benign fibrocystic disease of the breast with 2-bromo-alpha-ergocryptine (CB 154).
    Santoro C; Cappa M; Moretti C; Fabbri A; La Vecchia V; Romano Marcellino L; Fraioli F
    Int J Clin Pharmacol Ther Toxicol; 1982 Oct; 20(10):479-81. PubMed ID: 6815107
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Hormone treatment of benign breast diseases].
    Mauvais-Jarvis P
    Bull Cancer; 1991; 78(4):365-71. PubMed ID: 1859904
    [No Abstract]   [Full Text] [Related]  

  • 10. Effect of 2 br-alpha-ergocryptin (CB 154) on serum prolactin and the clinical picture in a case of progressive gigantomastia in pregnancy.
    Kullander S
    Ann Chir Gynaecol; 1976; 65(4):227-33. PubMed ID: 970897
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Hormonal treatment of non-malignant diseases of the breast].
    Strnad P; Cech E; Vachousek J; Smejkal V; Velek J
    Cas Lek Cesk; 1995 Feb; 134(3):67-72. PubMed ID: 7712528
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Failure of bromocriptine therapy to control juvenile mammary hypertrophy.
    Arscott GD; Craig HR; Gabay L
    Br J Plast Surg; 2001 Dec; 54(8):720-3. PubMed ID: 11728119
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Hormonal therapy of benign breast disease].
    Euller A; Kemeter P; Feichtinger W; Nasr F
    Gynakol Rundsch; 1980 Jun; 20 Suppl 2():58-63. PubMed ID: 7011918
    [No Abstract]   [Full Text] [Related]  

  • 14. [Therapy of the premenstrual syndrome and especially of cyclic mastodynia with bromocriptine].
    Hauser GA
    Ther Umsch; 1983 Jul; 40(7):604-9. PubMed ID: 6684802
    [No Abstract]   [Full Text] [Related]  

  • 15. Prolactin response to thyrotropin-releasing hormone as a guideline for cyclical mastalgia treatment.
    Rea N; Bove F; Gentile A; Parmeggiani U
    Minerva Med; 1997 Nov; 88(11):479-87. PubMed ID: 9433398
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hyperprolactinemia and mammary prostheses. A report of eight cases.
    Ruíz-Velasco V
    J Reprod Med; 1986 Apr; 31(4):267-70. PubMed ID: 3712366
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment of fibrocystic disease of the breast with a prolactin inhibitor: 2-Br-alpha-ergocryptine (CB-154).
    Martin-Comin J; Pujol-Amat P; Cararach V; Davi E; Robyn C
    Obstet Gynecol; 1976 Dec; 48(6):703-6. PubMed ID: 1036613
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [The effect of cyclic administration of progestagens on blood coagulation factors].
    Winkler UH; Lauck US; Ebert C; Schindler AE
    Zentralbl Gynakol; 1998; 120(1):32-7. PubMed ID: 9499549
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Hormonal disorders in mastopathy and their correction (a review of the literature)].
    Filatov AA
    Sov Med; 1978 Jun; (6):107-10. PubMed ID: 354023
    [No Abstract]   [Full Text] [Related]  

  • 20. [Why should benign mastopathies be treated medically?].
    Mauvais-Jarvis P
    J Gynecol Obstet Biol Reprod (Paris); 1985; 14(5):623-6. PubMed ID: 4067217
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.